These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36997081)

  • 41. Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy.
    Lazorwitz A; Coleman-Minahan K; Teal SB; Guiahi M
    J Adolesc Health; 2018 Sep; 63(3):363-364. PubMed ID: 30076014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
    Margatho D; Carvalho NM; Bahamondes L
    Eur J Contracept Reprod Health Care; 2020 Apr; 25(2):133-140. PubMed ID: 32069126
    [No Abstract]   [Full Text] [Related]  

  • 43. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
    Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
    Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Avoiding unintended pregnancy during transition from copper intrauterine device to etonogestrel contraceptive implant: A case report.
    Sulger E; Jung C; Nippita S
    Contraception; 2023 Aug; 124():110085. PubMed ID: 37257551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
    Mäkäräinen L; van Beek A; Tuomivaara L; Asplund B; Coelingh Bennink H
    Fertil Steril; 1998 Apr; 69(4):714-21. PubMed ID: 9548163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of plasma etonogestrel concentrations sampled from the contralateral-to-implant and ipsilateral-to-implant arms of contraceptive implant users.
    Gertz AM; Bishop IJ; Simon B; Lechiile K; Badubi O; Mussa A; Westhoff CL; Morroni C
    Contraception; 2020 Dec; 102(6):403-405. PubMed ID: 32858051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immediate postpartum initiation of etonogestrel-releasing implant: A randomized controlled trial on breastfeeding impact.
    Braga GC; Ferriolli E; Quintana SM; Ferriani RA; Pfrimer K; Vieira CS
    Contraception; 2015 Dec; 92(6):536-42. PubMed ID: 26209863
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
    Margatho D; Mota Carvalho N; Eloy L; Bahamondes L
    Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):344-350. PubMed ID: 30372645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A UPLC-MS/MS method for therapeutic drug monitoring of etonogestrel.
    Thomas T; Petrie K; Shim J; Abildskov KM; Westhoff CL; Cremers S
    Ther Drug Monit; 2013 Dec; 35(6):844-8. PubMed ID: 24081205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Comparison of Breastfeeding Exclusivity and Duration Rates Between Immediate Postpartum Levonorgestrel Versus Etonogestrel Implant Users: A Prospective Cohort Study.
    Krashin JW; Lemani C; Nkambule J; Talama G; Chinula L; Flax VL; Stuebe AM; Tang JH
    Breastfeed Med; 2019; 14(1):69-76. PubMed ID: 30508390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant.
    Deokar AM; Jackson W; Omar HA
    Int J Adolesc Med Health; 2011; 23(1):75-7. PubMed ID: 21721368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-acting reversible contraception with etonogestrel implants in female macaques (
    Maaskant A; Scarsi KK; Meijer L; Roubos S; Louwerse AL; Remarque EJ; Langermans JAM; Stammes MA; Bakker J
    Front Vet Sci; 2023; 10():1319862. PubMed ID: 38260208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
    Moeti DMP; Govender I; Bongongo T
    S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Etonogestrel implant use in women primarily choosing a combined oral contraceptive pill: A proof-of-concept trial.
    Chen MJ; Hsia JK; Creinin MD
    Contraception; 2018 Jun; 97(6):533-537. PubMed ID: 29496473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.
    Davies GC; Feng LX; Newton JR; Van Beek A; Coelingh-Bennink HJ
    Contraception; 1993 Mar; 47(3):251-61. PubMed ID: 8462316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial.
    Vieira CS; de Nadai MN; de Melo Pereira do Carmo LS; Braga GC; Infante BF; Stifani BM; Ferriani RA; Quintana SM
    Contraception; 2019 Oct; 100(4):258-263. PubMed ID: 31145885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.
    Ireland LD; Goyal V; Raker CA; Murray A; Allen RH
    Contraception; 2014 Sep; 90(3):253-8. PubMed ID: 24973904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic.
    Barbieri MM; Herculano TB; Dantas Silva A; Bahamondes L; Juliato CRT; Surita FG
    Int J Gynaecol Obstet; 2021 Jul; 154(1):106-112. PubMed ID: 33656758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.